Fred Restaino, based in United States, is currently a Sr. Director Clinical Supply Chain at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company. Fred Restaino brings experience from previous roles at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Taysha Gene Therapies, Clinical Supply Management, Inc. and Gilead Sciences. Fred Restaino holds a B.S in Pharmacy @ Philadelphia College of Pharmacy & Science. With a robust skill set that includes 21 CFR Part 11, Biopharmaceuticals, Biotechnology, CMC, CRO and more. Fred Restaino has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Fred Restaino?
Find contact details for 700 million professionals.